STOCK TITAN

Clearside Biomedical, Inc. (CLSD) Net Income by Year

CLSD

Clearside Biomedical, Inc. reported a net loss of $34.4M in fiscal year 2024. This represents a decrease of 5.7% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to a $26.0M net loss. The table below carries 11 fiscal years, from 2014 to 2024, and the quarters Clearside Biomedical, Inc. has filed alongside them.

FY2024 annual
Net Income -$34.4M
YoY -5.7%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Sep 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CLSD Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14
Net Income-$26.0M-$34.4M-5.7%-$32.5M+1.4%-$32.9M-8862.5%$376K+102.1%-$18.2M+40.8%-$30.8M+62.8%-$82.8M-40.4%-$59.0M-127.9%-$25.9M-46.7%-$17.6M-73.1%-$10.2M

TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

CLSD Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2510-QQ2'2510-QQ1'25Q4'2410-QQ3'2410-QQ2'2410-QQ1'24Q4'23Q3'23Q2'23Q1'23Q4'22
Net Income-$6.0M+22.3%-$4.5M+40.8%-$8.2M+30.1%-$7.3M-51.2%-$7.7M+17.0%-$7.6M+16.6%-$11.8M-26.8%-$4.8M+50.0%-$9.3M-18.4%-$9.1M-16.5%-$9.3M-21.4%-$9.7M-151.6%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Clearside Biomedical, Inc. financials

Frequently Asked Questions

What was Clearside Biomedical, Inc.'s net income in fiscal year 2024?

Clearside Biomedical, Inc. reported a net loss of $34.4M in fiscal year 2024.

How fast is Clearside Biomedical, Inc.'s net income growing?

Clearside Biomedical, Inc. (CLSD) net income fell by 5.7% year over year, from -$32.5M to -$34.4M in fiscal year 2024.

What is Clearside Biomedical, Inc.'s net income over the last twelve months?

Clearside Biomedical, Inc. (CLSD) reported a $26.0M net loss over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

Across the 11 fiscal years this page covers, Clearside Biomedical, Inc. (CLSD) net income went from -$10.2M in fiscal year 2014 to -$34.4M in fiscal year 2024.

Clearside Biomedical, Inc. (CLSD) reported -$6.0M in net income in Q3 2025. This represents an increase of 22.3% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Clearside Biomedical, Inc. (CLSD) reported on that line in every period on record.